Drugs / DC1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02787915 | Sep 2016 → Aug 2019 | renal cell carcinoma | Xuzhou Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02787915 ↗ |
| Route | Subcutaneous | “subcutaneous injection (3million cells) DC1 vaccines” NCT02787915 ↗ |